Trastuzumab
Also known as Herceptin (us), Canmab (india)
A monoclonal antibody (and biosimilars) for HER2-positive breast and stomach cancers, given by infusion.
United States
$1,506
per month
India
$601
per month
You save
−60%save $905/mo · 60% cheaper
919 US scripts/yr$831.6K potential annual savings$1.4M US spend/yr
Compare the price
US price$1,5063-week cycle
India price$6013-week cycle
You save$90560% less
Based on 1 vial 3-week cycle. US $1,505.59 vs India $600.71 per vial.
Total over 1 periodSave $905$1,506 → $601
The bigger picture
Trastuzumab is filled about 919 times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$1.4M
If sourced from India
$552.1K
Potential annual savings
$831.6K
−60%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.